Concepedia

Author

Federica Iannelli

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"ORCID

Also Known As

F Iannelli, F. Iannelli, Federica Iannelli, Iannelli, Federica, federica iannelli

39

Publications

524

Citations

11

H-Index

9

Concepts

All Affiliations

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"University of Naples Federico II
FI

About

Federica Iannelli is an author at Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" specializing in tumor biology, cancer cell biology, and cancer biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

21

2

Cell Biology

1

1

21

3

Cancer Cell Biology

1

1

21

4

Cell Signaling

1

1

21

5

Tumor Biology

1

1

21

Federica Iannelli

×

8

Publications

323

Citations

8

H-Index

YearCitations

Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation

Chiara Ciardiello, Alessandra Leone, Paola Lanuti,

Journal of Experimental & Clinical Cancer Research

2019

117

Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition

Federica Iannelli, Maria Serena Roca, Rita Lombardi,

Journal of Experimental & Clinical Cancer Research

2020

56

HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation

Maria Serena Roca, Tania Moccia, Federica Iannelli,

Journal of Experimental & Clinical Cancer Research

2022

41

Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance

Federica Iannelli, Andrea Ilaria Zotti, Maria Serena Roca,

Frontiers in Cell and Developmental Biology

2020

30

Vorinostat Potentiates 5-Fluorouracil/Cisplatin Combination by Inhibiting Chemotherapy-Induced EGFR Nuclear Translocation and Increasing Cisplatin Uptake

Geny Piro, Maria Serena Roca, Francesca Bruzzese,

Molecular Cancer Therapeutics

2019

24

Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype

Maria Rita Milone, Biagio Pucci, Katia Bifulco,

Oncotarget

2014

21

HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer

Rita Lombardi, Maura Sonego, Biagio Pucci,

Molecular Oncology

2020

19

Proteomic characterization of peroxisome proliferator‐activated receptor‐γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype

Maria Rita Milone, Biagio Pucci, Tommaso Colangelo,

Molecular Oncology

2016

15

Page 1